Samuel Klein on GLP-1 Revolution, Metabolism, and the Future of Obesity Medicine
Dr. Samuel Klein, Division Chief and William H. Danforth Professor of Medicine and Nutritional Science at Washington University Medicine, joins The Future of Medicine for a conversation about obesity, metabolism, insulin resistance, and the revolution sparked by GLP-1 medications like Ozempic. In this episode, Dr. Klein explains why obesity is far more biologically complex than many people realize — and why some individuals with obesity remain metabolically healthy while others develop diabetes, heart disease, and fatty liver disease. The conversation explores how fat functions not only as stored energy, but also as an active endocrine organ that communicates with the rest of the body through hormones and inflammatory signaling molecules. Dr. Klein discusses visceral fat, insulin resistance, inflammation, and why procedures like liposuction do not produce the same metabolic benefits as weight loss through diet, surgery, or GLP-1 medications. Dr. Klein also reflects on the unexpected rise of GLP-1 therapies, including how medications originally developed for diabetes transformed obesity treatment and may hold broader implications for cardiovascular disease, addiction, and other chronic conditions. Together, Dr. Klein and Euan Ashley discuss the future of metabolic medicine, precision approaches to obesity care, and why understanding metabolism may reshape the future of healthcare itself. Thank you for watching! 🔔 Subscribe for more conversations on groundbreaking medical science and innovation. Links: – Listen to the podcast: https://thefutureofmedicine.buzzsprou... – Subscribe to our channel: @stanforddepartmentofmedicine Chapters 00:00 GLP-1 Therapy Impact 01:55 Obesity & Metabolism 03:43 Obesity: Not Always Bad ️ 05:11 Fat Tissue Signals 07:05 Fat: Endocrine Function 09:02 Insulin Resistance 11:29 Liposuction Studies 12:58 Visceral Fat Impact 14:31 GLP-1 Medications 16:55 GLP-1 Unexpected Use 18:30 Metabolically Healthy 20:46 Inflammation Question 22:32 Precision Medicine 25:50 Multi-Organ System 27:22 Future of Medicine

Crystal Mackall on CAR-T Breakthroughs, Beating Childhood Cancer, and the Future of Cell Therapy

The obesity expert: 3 shocking truths about Ozempic side effects, and how to avoid them

Let’s satisfy our eyes, our stress reliever

What Happens When You Stop ‘Skinny Jabs’? | BBC News

Why GLP-1s may or may not be for you | Chasing Life

Bonnie Maldonado on Smallpox Eradication, Vaccine Hesitancy, and the Return of Measles

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

World-leading metabolic expert: How intermittent fasting can switch off your appetite in just 3 days

What are some of the key issues facing Australia? - World Questions podcast, BBC World Service

Stephen Quake on Safer Prenatal Genetic Testing, and Detecting Disease Earlier

Are We Using GLP-1 Medications All Wrong? with Dr. Ben Bikman

"Israel: What Went Wrong?": Holocaust Scholar Omer Bartov & Haaretz's Gideon Levy Debate Zionism

Inflammation Expert: Reverse silent inflammation with simple daily habits | Prof. Janet Lord

Übergewicht: Sind Abnehmspritzen ein echter Ausweg? | SWR Doku

Change is Hard: Challenges in Transforming Medical Education | MGR | 15 April 2026

Robert Wachter on the Digital Doctor, the Trust Gap, and Medicine's Next Giant Leap

Why I Take Low-Dose Tirzepatide (Zepbound)

Matcha, coffee and green tea: which is healthiest? with Prof. Tim Spector and Chef Andrew Kojima

Public Health in Crisis: What It Means to You | MGR | 18 March 2026

